|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2787 USD | -0.78% |
|
-9.37% | -57.77% |
Senti Biosciences, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 18.72 million compared to USD 18.21 million a year ago. Basic loss per share from continuing operations was USD 0.42 compared to USD 0.35 a year ago.
Basic loss per share was USD 0.42 compared to USD 0.42 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -57.77% | 13.27M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
SENTI BIOSCIENCES, INC. 
